Tolvaptan Works Long Term in Autosomal Dominant Polycystic Kidney Disease Tolvaptan Works Long Term in Autosomal Dominant Polycystic Kidney Disease

A new study demonstrates the long-term efficacy of the vasopressin-2 receptor antagonist tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD).Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news